Nib New Zealand [ASX: NHF], which acquired Tower Medical Insurance late 2012 to become New Zealand's second-largest health insurer, says it has halted Tower's customer losses, achieving modest growth by targeting the under 40s market.
The local arm of the listed Australian insurance company contributed $3.5 million to its parent's first-half pretax earnings from underwriting in the six months ended Dec. 31.
Sydney-based nib Holdings separately reported interim net profit rose 9.2 percent to A$39.6 million as premium revenue growth jumped 20 percent and said its New Zealand business "is now growing policyholders after six years of steady decline."
The Australian insurer acquired Tower Medical Insurance in November 2012 for $102 million, and launched nib New Zealand last October. It says policyholders at Tower Medical, since rebranded as nib New Zealand, have grown by 0.1 percent to 79,324, or about 9 percent of the entire nib group, since June 30, after six years of annual declines averaging 4 percent.
The insurer is targeting younger customers, with about 60 percent of direct consumer sales in New Zealand being people under 40 and 50 percent of sales made online.
"We are confident our investment to grow New Zealand private health insurance participation and with that our market share, will be a driver of future and sustainable earnings growth," Rob Hennin, nib New Zealand chief executive, said in a statement.
The parent confirmed full year operating profit guidance of A$73 million to A$80 million. Earnings per share gained 8.4 percent to 9 Australian cents in the first half.
Its shares rose 1.2 percent to A$2.61 on the ASX and have declined 5.5 percent this year.
This article is tagged with the following keywords. Find out more about MyNBR Tags
- Helen Kelly says she's taken cannabis oil — and wants the govt to make it legal for cancer suffers
- TPP allows for a tax on foreign buyers — Groser
- The Martian: Blows Gravity and Interstellar out of the water
- On vets, specialists and debt collectors – a rave!
- Comment: Co-operative becomes a fiction in Silver Fern Farms deal